Michael F McEntee
Overview
Explore the profile of Michael F McEntee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ackermann A, Frank L, McEntee M, May E
Vet Dermatol
. 2015 Jul;
26(5):391-2, e89.
PMID: 26189440
This report describes a dog that developed erythema multiforme in temporal association with administration of the sulphonamide-based anticonvulsant drug zonisamide. Similar adverse drug reactions have been associated with sulphonamide antimicrobial...
2.
Wang R, Aminian A, McEntee M, Kan S, Simonaro C, Lamanna W, et al.
Mol Genet Metab
. 2014 Jun;
112(4):286-93.
PMID: 24951454
Background: Treatment with intravenous enzyme replacement therapy and hematopoietic stem cell transplantation for mucopolysaccharidosis (MPS) type I does not address joint disease, resulting in persistent orthopedic complications and impaired quality...
3.
Huang E, Zhao Y, Chen G, Baek S, McEntee M, Minkin S, et al.
BMC Complement Altern Med
. 2014 Feb;
14:68.
PMID: 24555771
Background: Zyflamend, a mixture containing extracts of ten herbs, has shown promise in a variety of preclinical cancer models, including prostate cancer. The current experiments were designed to investigate the...
4.
MacFarlane A, McEntee M, Stover P
J Nutr
. 2014 Feb;
144(4):419-24.
PMID: 24500934
Folate metabolism affects DNA synthesis, methylation, mutation rates, genomic stability, and gene expression, which are altered in colon cancer. Serine hydroxymethyltransferase 1 (SHMT1) regulates thymidylate (dTMP) biosynthesis and uracil accumulation...
5.
Zhang X, Lee S, Min K, McEntee M, Jeong J, Li Q, et al.
Cancer Prev Res (Phila)
. 2013 Oct;
6(12):1337-47.
PMID: 24104354
The nonsteroidal anti-inflammatory drug tolfenamic acid has been shown to suppress cancer cell growth and tumorigenesis in different cancer models. However, the underlying mechanism by which tolfenamic acid exerts its...
6.
Huang E, McEntee M, Whelan J
Nutr Cancer
. 2012 Jun;
64(5):749-60.
PMID: 22663543
Prostate cancer (PrC) is the second deadliest cancer of males in the United States Hormone deprivation therapy (HDT), a common therapy for advanced forms of the disease, results in tumor...
7.
Huang E, Chen G, Baek S, McEntee M, Collier J, Minkin S, et al.
Nutr Cancer
. 2011 Oct;
63(8):1287-96.
PMID: 21958043
Prostate cancer is the most commonly diagnosed solid malignancy, and tumor cells eventually transform to castrate resistance through multiple pathways including activation of the androgen receptor via insulin-like growth factor...
8.
Newkirk K, Atkins R, Dickson P, Rohrbach B, McEntee M
Invest Ophthalmol Vis Sci
. 2011 Mar;
52(8):5130-5.
PMID: 21436264
Purpose: Mucopolysaccharidosis I (MPS I) is an inherited metabolic disorder resulting from deficiency of α-L-iduronidase and lysosomal accumulation of glycosaminoglycans (GAG) in multiple tissues. Accumulation of GAG in corneal stromal...
9.
MacFarlane A, Perry C, McEntee M, Lin D, Stover P
Cancer Res
. 2011 Mar;
71(6):2098-107.
PMID: 21406397
Folate-mediated one-carbon metabolism is required for the de novo synthesis of purines, thymidylate, and S-adenosylmethionine, the primary cellular methyl donor. Impairments in folate metabolism diminish cellular methylation potential and genome...
10.
Lyons J, Dickson P, Wall J, Passage M, Ellinwood N, Kakkis E, et al.
Lab Invest
. 2011 Mar;
91(5):665-74.
PMID: 21383673
Mucopolysaccharidosis-I (MPS-I) is an inherited deficiency of α-L-iduronidase (IdU) that causes lysosomal accumulation of glycosaminoglycans (GAG) in a variety of parenchymal cell types and connective tissues. The fundamental link between...